Myval heart valve replacement in people with severe aortic valve stenosis
Follows safety and performance of the Myval valve in adults with severe aortic stenosis.
Key facts
- Who runs it
- Portuguese Association of Interventional Cardiology
- Where
- Carnaxide, Coimbra, Evora, Lisbon, and Porto, PortugalSee the 6 sites
- Trial code
- Registry title
- Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 13 May 2025
- Expected to end
- Nov 2028
- Type of study
- Observational
- Treatments tested
- Myval THV series
- Record updated
- 16 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with severe aortic valve narrowing that causes symptoms. Their heart team plans to replace the valve through a catheter (TAVI) using the Myval THV series.
- Age
- Over 18 years
- Sex
- All sexes
- Disease stage
- Symptomatic severe narrowing of the person's own aortic valve (aortic stenosis).
Main reasons for not taking part
- Allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast dye
- Ongoing infection of the heart lining (infective endocarditis) or a similar infection
- Pregnant or breastfeeding
- Liver failure (Child-Pugh Class B or C)
- Taking part in another clinical study that has not reached its main goal
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patient over the age of 18 years with symptomatic aortic stenosis (severe AS), intended to perform TAVI procedure using Myval THV series as assessed by Heart Team
- Patient has provided written informed consent as approved by the Ethics Committee (EC)
- Patient is willing to undergo all registry procedures and follow-up requirements
Who cannot take part
- Patients with hyper sensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast media
- Ongoing infective endocarditis or any similar infection
- Liver failure (Child-Pugh Class B or C)
- Any condition, which in the investigator opinion, would preclude safe participation of the patient in the Registry
- Pregnant or lactating females
- Patient is currently participating in another clinical investigation where the primary endpoint has not been achieved
Where in Portugal
- Unidade Local de Saúde do Lisboa Ocidental E.P.E. - Hospital Santa CruzCarnaxide, PortugalContact: Sílvio Leal, MDTaking people
- Unidade Local de Saude de CoimbraCoimbra, PortugalContact: Joana D Silva, Prof. Dr.Taking people
- Unidade Local de Saúde Alentejo Central E.P.E. - Hospital Espírito SantoEvora, PortugalContact: Lino Patrício, Prof. Dr.Taking people
- Unidade Local de Saúde de Santa Maria, E. P. E. - Hospital de Santa MariaLisbon, PortugalContact: Pedro C Ferreira, MDTaking people
- Unidade Local de Saúde de São José E.P.E. - Hospital Santa MartaLisbon, PortugalContact: Duarte Cacela, MDNot yet recruiting
- Unidade Local de São João E.P.E.Porto, PortugalContact: Domingos MagalhãesNot yet recruiting
About the trial
What the trial wants to find out
A prospective, single-arm, multi-centre registry to evaluate the safety and performance of Myval THV series using Transcatheter Aortic Valve Implantation (TAVI) procedure in patients with symptomatic severe native aortic valve stenosis.
Treatments tested
- Myval THV series
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry
- Plain-language title
- Myval heart valve replacement in people with severe aortic valve stenosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 16 January 2026